A Landmark Immuno-Oncology Event in Villejuif
On June 24, 2026, the Paris-Saclay Cancer Cluster (PSCC) will host a major international event dedicated to immuno-oncology at The Hive, Campus Grand Parc in Villejuif.
As a partner, we are proud to support this high-level scientific gathering, bringing together some of the most influential leaders shaping the future of cancer research and immunotherapy.
World-leading experts gathered in one place
This exclusive event will feature a remarkable lineup of internationally renowned researchers and clinicians, including James P. Allison, Nobel Prize laureate and pioneer of immune checkpoint therapy.
He will be joined by leading scientists from top institutions such as Gustave Roussy, MD Anderson Cancer Center, and UCSF, all sharing the latest breakthroughs and perspectives in the field.
Event details
- Date: June 24, 2026
- Location: The Hive, PSCC – Villejuif, France
- Format: Full-day scientific program
Limited attendance
Due to high demand and limited capacity, on-site participation will be confirmed after registration. Selected participants will receive a confirmation email with further details.
Driving the next wave of innovation in oncology
This event highlights the momentum of innovation in immuno-oncology and reinforces PSCC’s role as a leading hub for collaboration between researchers, clinicians, and industry stakeholders.